MA
GILD icon

MJP Associates’s Gilead Sciences GILD Stock Holding History

MJP Associates’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$371K Buy
2,940
+54
+2% +$7.12K 0.04% 147
2026
Q1 		$402K Buy
2,886
+225
+8% +$31.5K 0.05% 134
2025
Q4 		$327K Buy
2,661
+532
+25% +$64.7K 0.04% 183
2025
Q3 		$236K Buy
2,129
+276
+15% +$31.4K 0.03% 221
2025
Q2 		$205K Buy
+1,853
New +$197K 0.03% 222
2023
Q3 		– Sell
-6,023
Closed -$464K – 178
2023
Q2 		$464K Sell
6,023
-967
-14% -$77.1K 0.15% 76
2023
Q1 		$580K Buy
6,990
+412
+6% +$34.1K 0.18% 61
2022
Q4 		$565K Buy
6,578
+865
+15% +$68.5K 0.16% 68
2022
Q3 		$352K Buy
5,713
+783
+16% +$49.4K 0.11% 84
2022
Q2 		$305K Buy
+4,930
New +$305K 0.09% 97

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

MJP Associates's GILD Position: Q2 2026 in Review

MJP Associates increased its Gilead Sciences (GILD) stake by 1.9% in Q2 2026, buying an estimated $7.12K and bringing the position to 2,940 shares worth $371K. The position accounts for 0.04% of the portfolio, ranked #147.

MJP Associates first reported a position in GILD in Q2 2022 and has held it in 10 quarters since. The position peaked at $580K in Q1 2023. 2,291 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • MJP Associates held 2,940 shares of Gilead Sciences worth $371K as of Q2 2026.
  • MJP Associates bought 54 Gilead Sciences shares in Q2 2026, an estimated $7.12K.
  • Gilead Sciences made up 0.04% of MJP Associates's portfolio in Q2 2026, its #147 holding.
  • MJP Associates first reported a position in Gilead Sciences in Q2 2022 and has held it in 10 quarters since.
  • MJP Associates's Gilead Sciences position peaked at $580K in Q1 2023.
  • 2,291 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on MJP Associates's 13F filing for Q2 2026, filed 11 Aug 2026.